DiaMedica Therapeutics Inc.
DMAC
$6.59
$0.050.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.97% | -14.90% | -1.39% | -11.96% | 0.10% |
| Total Depreciation and Amortization | 9.09% | 0.00% | -38.89% | 500.00% | -72.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.47% | -31.95% | 21.95% | 28.97% | -2.40% |
| Change in Net Operating Assets | 253.22% | 9,733.33% | -99.76% | 346.39% | -549.37% |
| Cash from Operations | 10.66% | -16.96% | -18.55% | 13.79% | -6.28% |
| Capital Expenditure | 62.50% | -33.33% | 62.50% | -166.67% | 50.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 491.55% | -126.32% | 131.07% | -387.29% | 35.11% |
| Cash from Investing | 489.92% | -126.44% | 131.03% | -387.66% | 35.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -50.00% | 33.33% | -50.00% | 33.33% |
| Issuance of Common Stock | -67.86% | -96.51% | -62.37% | 19,526.99% | 73.40% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 112.28% | -- | -- |
| Cash from Financing | -68.35% | -96.55% | -61.66% | 19,485.71% | 76.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.42% | -187.48% | 1,673.56% | -151.51% | 448.62% |